Skip to main content

Table 2 Hemodynamic data

From: Effects of remimazolam combined with sufentanil on hemodynamics during anesthetic induction in elderly patients with mild hypertension undergoing orthopedic surgery of the lower limbs: a randomized controlled trial

Item

Group

T0

T1

T2

T3

T4

MAP(mmHg)

      
 

Group R

102.7 ± 8.6

98.3 ± 6.5

100.7 ± 8.5

99.3 ± 7.4

98.5 ± 7.9

 

Group P

103.8 ± 7.7

71.3 ± 6.2a*

86.7 ± 7.7a*

82.3 ± 7.3a

81.7 ± 7.6a

P value

 

0.604

< 0.001

< 0.001

< 0.001

< 0.001

HR(bpm)

      
 

Group R

78.9 ± 9.5

75.7 ± 8.5

76.9 ± 9.3

76.5 ± 8.9

75.9 ± 8.6

 

Group P

77.5 ± 8.9

59.8 ± 9.4a*

63.7 ± 8.9a*

65.8 ± 8.4a*

64.9 ± 9.1a*

P value

 

0.558

< 0.001

< 0.001

< 0.001

< 0.001

SP02(%)

      
 

Group R

95.7 ± 1.5

98.2 ± 0.9

99.2 ± 0.4

99.7 ± 0.6

99.8 ± 0.4

 

Group P

96.3 ± 1.2

98.6 ± 0.7

99.4 ± 0.6

99.5 ± 0.7

99.6 ± 0.6

P value

 

0.093

0.060

0.134

0.240

0.134

CO(L/min)

      
 

Group R

4.5 ± 0.7

4.2 ± 0.6

4.4 ± 0.6

4.3 ± 0.5

4.4 ± 0.6

 

Group P

4.6 ± 0.6

3.2 ± 0.6a*

3.4 ± 0.7a*

3.6 ± 0.6a*

3.6 ± 0.5a*

P value

 

0.555

< 0.001

< 0.001

< 0.001

< 0.001

CI(L/min/m2)

      
 

Group R

3.5 ± 0.9

3.3 ± 0.6

3.4 ± 0.5

3.4 ± 0.4

3.4 ± 0.6

 

Group P

3.6 ± 0.8

2.6 ± 0.7a*

2.7 ± 0.6a*

2.9 ± 0.3a*

2.9 ± 0.4a*

P value

 

0.651

< 0.001

< 0.001

< 0.001

< 0.001

SVR(dyn·s/cm5)

      
 

Group R

990 ± 110

1006 ± 129

1115 ± 124

1166 ± 127

1105 ± 124

 

Group P

985 ± 116

2556 ± 136a*

2010 ± 128a*

1955 ± 131a*

1943 ± 121a*

P value

 

0.865

< 0.001

< 0.001

< 0.001

< 0.001

  1. Data are presented as mean ± standard deviation
  2. aP<0.05 compared with T0
  3. *P < 0.05 compared with Group P
  4. MAP: mean arterial pressure; HR: heart rate; SpO2, pulse oxygen saturation; CO: cardiac output; CI: cardiac index; SVR: systemic vascular resistance